KIMBERLY NEACE: Open Payments
NPI 1619578218 · MARION, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$585 in 31 payments from 8 companies in 2025. Trend: 2023 $866 · 2024 $837 · 2025 $585
Food & beverage: $585
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $150 |
| Alkermes, Inc. | 5 | $82 |
| Teva Pharmaceuticals USA, Inc. | 4 | $77 |
| Vanda Pharmaceuticals Inc. | 3 | $63 |
| ABBVIE INC. | 3 | $62 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Lundbeck LLC | 2 | $49 |
| Neurocrine BioSciences, Inc. | 2 | $49 |
Products named: COBENFY, REXULTI, ARISTADA, AUSTEDO XR, VRAYLAR, INGREZZA, FANAPT, HETLIOZ.
Industry payments across OH — which companies pay providers there.
